Ciprofloxacinresistant Salmonella Kentucky in TravelersTo the Editor: Ciprofloxacin is the treatment of choice of severe nontyphoidal Salmonella infections in adults.Resistance to ciprofloxacin has been found exceptionally in nontyphoidal Salmonella enterica isolates and only in serotypes Typhimurium, Choleraesuis, and Schwarzengrund (1-8).Such isolates have been collected from humans and animals in Europe, Asia, and North America.We report the emergence of ciprofloxacin-resistant isolates of S. Kentucky since 2002 in French travelers returning from northeast and eastern Africa.From 2000 through 2005, 197 S. Kentucky isolates from humans (1 per patient) were serotyped, from 69,759 total S. enterica isolates serotyped at the French National Reference Centre for Salmonella.Antimicrobial drug sus-
No takes yet. Share an insight, caveat, or question.
Weill et al. (2006) studied this question.